Skin and Subcutaneous Tissue Disorders: Skin rash.
The following events have been reported: Nervous System Disorders: Dizziness, headache.
Eye Disorders: Corneal oedema and erosions, conjunctivitis, eyelash and vellus hair changes (increased length, thickness, pigmentation, and number), iritis/uveitis, keratitis, macular oedema (including cystoid macular oedema), misdirected eyelashes sometimes resulting in eye irritation, vision blurred (see PRECAUTIONS).
Respiratory, Thoracic and Mediastinal Disorders: Asthma, asthma aggravation, acute asthma attacks, and dyspnea.
Skin and Subcutaneous Tissue Disorders: Darkening of the palpebral skin of the eyelids and localized skin reaction on the eyelids.
Musculoskeletal and Connective Tissue Disorders: Muscle/joint pain.
General Disorders and Administration Site Conditions: Non-specific chest pain.
Infections and Infestations: Not known: herpetic keratitis.
Case of corneal calcification have been reported very rarely in association with the use of phosphate-containing eye drops in some patients with significantly damaged corneas.
View ADR Reporting Link